Ju-Young Shin, PhD

Associate Professor
School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
Suwon, Republic of Korea

Disclosure information not submitted.

Presentation(s):

• Risk of Cardiovascular Events, Malignancy, and Serious Infection Associated With JAK inhibitors and TNF inhibitors in Rheumatoid Arthritis or Ulcerative Colitis: A Nationwide Cohort Study

  Monday, August 26, 2024
  2:45 PM – 3:00 PM CEST

• Risk of Facial Palsy Following COVID-19 Vaccination: A Nationwide Large-Linked Database Study

  Monday, August 26, 2024
  2:00 PM – 2:15 PM CEST

• Advancing Drug Safety Signal Management through Multimodal Approaches in Networking

  Monday, August 26, 2024
  3:30 PM – 5:00 PM CEST

• Acute Cardiovascular, Neurological and Metabolic Adverse Events Associated With The Use of Nirmatrelvir/ritonavir or Molnupiravir for COVID-19 Infection: a Nationwide Cohort Study in South Korea

  Monday, August 26, 2024
  6:30 PM – 6:45 PM CEST

• Glucagon-Like Peptide 1 Receptor Agonists and Risk of Thyroid Cancer: An International Multisite Cohort Study in Canada, Denmark, Norway, Sweden, South Korea and Taiwan

  Tuesday, August 27, 2024
  8:15 AM – 8:30 AM CEST

• Dementia Associated With Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-Like Peptide-1 Receptor Agonists: A Population-Based Cohort Study

  Tuesday, August 27, 2024
  1:30 PM – 1:45 PM CEST

• Emulating 6 Cardiovascular Outcome Trials of Antihyperglycemics in Patients with Type 2 Diabetes: A Multinational Analysis Based on 3 Asian Real-World Databases

  Tuesday, August 27, 2024
  1:40 PM – 1:45 PM CEST

• Risk of Hepatic Events Associated with Use of SGLT-2 Inhibitors Versus GLP-1RA, and Thiazolidinedione Among Patients with Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes

  Wednesday, August 28, 2024
  2:15 PM – 2:30 PM CEST